TNFR1 inhibition with a Nanobody protects against EAE development in mice.
about
Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease.A New Venue of TNF Targeting.Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory DiseasesAnti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
P2860
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@en
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@nl
type
label
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@en
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@nl
prefLabel
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@en
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@nl
P2093
P2860
P1433
P1476
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
@en
P2093
Christian Vanhove
Claude Libert
Filip De Vos
Griet Van Imschoot
Leen Vanhoutte
Riet De Rycke
Sara Van Ryckeghem
Wendy Toussaint
P2860
P2888
P356
10.1038/S41598-017-13984-Y
P407
P577
2017-10-20T00:00:00Z
P6179
1092252296